Schiff base derived from thiosemicarbazone and anthracene showed high potential in overcoming multidrug resistance in vitro with low drug resistance index
Jie Bai,1 Rui-Hui Wang,1 Yan Qiao,2 Aidong Wang,3 Chen-Jie Fang1 1Department of Chemical Biology, School of Pharmaceutical Sciences, Capital Medical University, Beijing, 2Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan, 3Department of Pharmaceu...
Saved in:
Main Authors: | Bai J (Author), Wang RH (Author), Qiao Y (Author), Wang A (Author), Fang CJ (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gibberellin derivative GA-13315 overcomes multidrug resistance in breast cancer by up-regulating BMP6 expression
by: Xianqiang Luo, et al.
Published: (2022) -
Overcoming Multidrug Resistance of Antibiotics via Nanodelivery Systems
by: Mohammad Imran, et al.
Published: (2022) -
Triphenylphosphonium-modified mitochondria-targeted paclitaxel nanocrystals for overcoming multidrug resistance
by: Xue Han, et al.
Published: (2019) -
Synthesis and cytotoxicity evaluation of thiosemicarbazones and their thiazole derivatives
by: Saulo Feheiberg Pinto Braga, et al. -
Genetic Variation Putatively Associated with <i>Mycobacterium tuberculosis</i> Resistance to Perchlozone, a New Thiosemicarbazone: Clues from Whole Genome Sequencing and Implications for Treatment of Multidrug-Resistant Tuberculosis
by: Igor Mokrousov, et al.
Published: (2020)